was based on the simple concept that collapse of target reprocedure based on tissue engineering principles, was performed in gions could be initiated using a washout solution to disrupt six sheep with papain-induced experimental emphysema (EMPH).
though the ultimate objective of the remodeling process is emphysema; tissue engineering to produce a mechanical response, this can only happen if an appropriate biologic response is first generated. Thus, we Lung volume reduction therapy refers to elimination of emhypothesized that redesigning BLVR to improve its safety physematous hyperinflated lung, which allows the remaining and effectiveness would require a method that mimics scar pulmonary parenchyma and the respiratory muscles to function more effectively (1) . Observational studies, and randomformation similar to what occurs during normal healing. ized clinical trials, provide convincing evidence that the proSuch responses in the lung are usually initiated by an cedure improves respiratory function, exercise capacity, and injury that causes loss of epithelial integrity, followed by symptoms of dyspnea in selected patients with advanced eminflammation leading to scar formation (12). The BLVR sysphysema (EMPH) to a greater extent than optimal medical tem has been designed to replicate key aspects of this healing therapy (1-7). To date, lung volume reduction in humans process without producing inflammation. This second generahas been accomplished exclusively through surgical means tion system uses an enzymatic primer solution to remove (lung volume reduction surgery [LVRS] ). Although the physepithelial cells from the target region and a modified hydrogel iologic and symptomatic benefits of LVRS have, on average, scaffold that contains glycosaminoglycans and a synthetic been quite impressive, substantial morbidity and mortality, polyamine to promote fibroblast attachment and collagen associated with major thoracic surgery and general anesthesia synthesis. The system was initially tested in control sheep in an elderly debilitated population, have limited the clinical without EMPH; it was well tolerated, and produced efficient utility of the procedure (8, 9).
scarring (11). The present study describes the application of We have demonstrated previously that lung volume reducthis novel tissue engineering approach to BLVR in a sheep tion can be accomplished bronchoscopically, a procedure that model of advanced homogeneous EMPH to confirm its safety, represents a potential alternative to LVRS (10) . The initial evaluate its ability to reduce lung volume, and improve physiapproach to bronchoscopic lung volume reduction (BLVR) ologic parameters.
(50 g/kg/min; Propoflo, Abbott Labs, Columbus, OH). A 10-mm-9-week post-BLVR studies, the animals were killed and autopsied. Gross and microscopic examinations were performed, and representadiameter endotracheal tube was inserted into the trachea under fiberoptic guidance and attached to a mechanical ventilator. An esophative photographic documentation was obtained. geal balloon was introduced through the nares, and the desired position Physiologic Measurements was verified by observing transpulmonary and transrespiratory system pressures, and cardiac oscillations on transpulmonary pressure profiles.
(1 ) Lung volume (functional residual capacity [FRC]) was measured Heart rate and arterial oxygen saturation were continuously monitored by whole body plethysmography during spontaneous breathing (D. using an oximeter and tongue probe.
Buxco Electronics, Sharon, CT). Intermittent airway occlusions were triggered remotely (outside the box) using a pneumatic shutter (PneuThe Experimental Model matic controller valve; Hans Rudolf Inc., Kansas City, MO), allowing for measurements of inspiratory efforts against a closed shutter and A model for advanced homogeneous EMPH was developed in six female sheep, weighing 67 Ϯ 22 kg. Seven animals were initially tested determination of intrathoracic gas volume based on Boyle's law (10).
(2 ) Pleural pressure was obtained during inspiratory efforts against a and found free of zoonoses (Chlamydia psittaci, Mycobacterium pseudotuberculosis, Brucella, and Coxiella burnetti). Under light anesthesia closed shutter at FRC and FRC ϩ 1.5 L, to characterize the pressurevolume (PV) relationship for the chest wall during respiratory muscle and controlled mechanical ventilation, Albuterol (five puffs) was administered through an in-line metered-dose inhaler (MDI) device to prevent contraction. (3 ) The deflation PV relationship for the lung measured from 30 cm H 2 O transpulmonary distending pressure was determined bronchospasm and to provide uniform distribution of the papain (Sigma Chemical, St. Louis, MO). Papain (75 U/kg weekly for 4 weeks) was by intermittent occlusion. (4 ) The PV relationship for the chest wall was measured in identical fashion to characterize the compliance chardelivered over 15 to Ϫ20 minutes using a parallel system of dual nebulizers (Pari LC Plus; Pari Respiratory Equipment, Midlothian, VA) conacteristics of the relaxed chest wall in the absence of muscle contraction.
(5 ) Airway resistance, tissue resistance, and dynamic elastance meanected to the positive pressure ventilator circuit through a series of one-way valves. Tidal volume was set at 12 ml/kg, rate at 12 breaths/ surements were determined to characterize the dynamic properties of the lung using the optimal ventilator waveform approach of Lutchen minute, and Fi O 2 at 0.6. One of the six animals developed pulmonary hemorrhage after the second dose of papain and was killed. Out of the and coworkers (13) with a computer-controlled large animal ventilator.
(6 ) Single breath diffusing capacity (Dl CO ) was measured by filling the remaining six animals, two experienced mild respiratory distress and cough after the first and second papain treatments. These clinical signs lung to total lung capacity (TLC) with tracer gas (10% helium/0.3% carbon monoxide/21% oxygen/balanced nitrogen) via a supersyringe, resolved after treatment with dexamethasone (0.1 mg/kg). No other adverse reaction to papain was noted.
and analyzing the expirate using a carbon monoxide/helium analyzer. These measurements essentially replicate the standard battery of cliniThe BLVR Procedure cal tests used to assess patients for LVRS. Chest CT scans were performed at resting end expiratory lung vol-A fiberoptic endoscope (GIF-n30 pediatric gastroscope; Olympus Corumes (FRC) and at full lung inflation (TLC). poration, Tokyo, Japan) with 5 mm outside diameter and 90 cm working length was introduced through the indwelling endotracheal tube and where V is volume, P pressure, Vmax the volume attained at "infinite" ing 10% heat inactivated fetal bovine serum) was delivered and left in distending pressure, A ϭ (Vmax Ϫ Vmin), Vmin is the volume at zero place for 2 minutes to neutralize residual primer. Suction was again distending pressure (equivalent to residual volume [RV]), and k is a applied. Ten milliliters of fibrin hydrogel suspension (3% fibrin conparameter describing the shape of the exponential relationship between taining 0.1% chondroitin-6-sulfate and 0.1% poly-l-lysine; Bistech) and pressure and volume (the shape factor). Results are reported in terms 1 ml of thrombin cross-linker (1,000 U thrombin in 1 ml of phosphateof the parameters Vmax, Vmin, and k. TLC is determined as the volume buffered saline containing 5 mM calcium chloride) were delivered simulintercept of the active chest wall PV relationship and the passive lung taneously at this site through a dual lumen catheter system. These PV relationship. The corresponding pressure at this point of intercept relatively small volume injectates were used to help avoid pressure is the recoil pressure at TLC. necrosis and sterile abscess formation that had been observed in prior Dynamic lung function measurements obtained using the optimal studies using injection volumes of 50 ml. This procedure was repeated ventilator waveform (OVW) technique were interpreted by fitting freat each of the six treatment sites. Individual treatments required approxquency domain expressions for pressure, volume, and flow data to the imately 5 to 7 minutes to complete, and the entire BLVR protocol took constant phase impedance model of Hantos and coworkers (15): 30 to 45 minutes. After completion of BLVR therapy, anesthesia was P()/V() ϭ Raw ϩ {(GϪHj)/ ␣ } discontinued and animals were monitored closely during recovery. Once clinically stable, each animal was returned to its stall.
where P is pressure, V is flow, is angular frequency in radians/second, The following six sites were selected for treatment in each sheep: j is the imaginary number ͌Ϫ1, Raw is airway resistance, and other (1 ) the dorsal segment of the right cardiac lobe, (2 ) the medial segment terms are as previously defined. Results are summarized in terms of of the right diaphragmatic lobe, (3 ) the caudal segment of the right airway resistance, tissue resistance (expressed as the dissipative modudiaphragmatic lobe, (4 ) the cranial segment of the left apical lobe, (5 ) lus G), and dynamic elastance (expressed as the elastic modulus H). the lateral segment of the left diaphragmatic lobe, and (6 ) the caudal Pleural pressure deflections measured during inspiratory efforts segment of the left diaphragmatic lobe. These sites included both depenagainst a closed shutter were assessed at FRC, and at FRC ϩ 1.5 L. dent and nondependent portions of the lung and were easily identified
The maximum inspiratory effort generated during a 60-to 90-second during bronchoscopy via direct visualization.
occlusion was recorded as the maximal inspiratory pleural pressure at the corresponding lung volume. Inspiratory PV data were used to Description of Experimental Protocol construct an "active chest wall" compliance relationship that was assumed to be linear between TLC and RV. Under anesthesia and controlled mechanical ventilation, detailed respiratory physiology measurements were performed and computerized Dl CO was determined in intubated, anesthetized sheep using an airtight three-way valve system, a calibrated carbon monoxide and tomography (CT) scans of the chest were obtained at baseline (BAS), 2 weeks after receiving a full course of papain on development of helium meter (Morgan Transfer factor system; Morgan Scientific, Haverhill, MA), source of calibrated tracer gas, and a 3-L syringe. A experimental EMPH but just before BLVR (EMPH), and 3 and 9 weeks after BLVR. Clinical status including activity levels, body weights, and volume of Dl CO -calibration gas equal to the inspiratory capacity for the sheep was drawn into the syringe, with the sheep lung volume at vital signs were monitored during follow-up. On completion of the FRC. The calibrated tracer gas was then injected into the sheep and full inflation maintained for 10 seconds. The injected volume of gas was withdrawn, and the expirate injected back through the meter to determine the concentration of expired carbon monoxide and helium. The alveolar volume was calculated from a single breath helium dilution measurement. Using alveolar volume and the breath hold time, Dl CO can then be calculated as: Dl CO ϭ [Va/(Pb Ϫ PH 2 O)] ϫ 60/breath hold time ϫ ln (Fi Aco /Ff Aco ). Va is the alveolar volume, Ff Aco is the measured fractional concentration of carbon monoxide at the end of the breath hold, Fi Aco , the initial alveolar concentration of carbon monoxide is equal to the injected concentration of carbon monoxide ϫ injected syringe volume/TLC.
Pathologic Anatomy
After completion of 9-week post-BLVR physiologic measurements, the animals were killed with intravenous pentobarbital (100 mg/kg) and autopsied. The lungs were removed, fully inflated, and the pulmonary circulation was then flushed with 2.5 L of normal saline at 20 cm H 2 O pressure. Sites of BLVR were readily detected by visual inspection and manual palpation, and were photographed. The lungs were sliced serially into 2 to 2.5 cm axial sections and further inspected for signs of scar formation or other gross changes. Samples from all BLVR treatment sites and representative samples from untreated sites were fixed in 15% buffered formalin and stained with hemotoxylin and eosin.
Statistical Analysis
Comparisons between physiologic parameters at different time points were performed by analysis of variance for repeated measures. Differ- Figure 1 . The Campbell diagram summarizes the relationship between ences between specific groups were identified using Duncan's post hoc lung of lung initially subtended by these airways. Active and passive increased. These values closely resemble changes observed in chest wall PV relationships did not significantly change in rehumans with advanced EMPH (17). Papain treatment caused a sponse to BLVR therapy. The improvements in lung function substantial decrease in Dl CO by 20.3% (from 47.9 Ϯ 13.7 to observed 3 weeks after treatment were still present and were 36.1 Ϯ 12.2 ml/min/mm Hg, p ϭ 0.019) indicating the presence similar in magnitude at the 9-week follow-up. The Campbell of tissue destruction and the loss of alveolar surface for gas diagram ( Figure 2 ) summarizing these results shows that the exchange.
volume reduction, and resizing of lung to chest wall produced The BLVR procedure was well tolerated. None of the animals by this procedure not only decreased trapped gas (RV-2 to RV-4) developed hypoxemia, hemoptysis, bronchospasm, or respiraand lung volumes (TLC-2 to TLC-4), but also increased recoil tory distress either during or after treatment. Arterial oxygen pressures (P2 to P4). saturation values measured before starting the procedure, and 10 A summary of the effects of BLVR on lung volumes throughminutes after completion of the procedure on the same ventilator out the study period is presented in Figure 3 . Animals with settings (Fi O 2 ϭ 0.6, tidal volume ϭ 12 ml/kg, breathing rate ϭ papain-induced EMPH exhibited increases in RV and TLC, a 12/min, and positive end expiratory pressure ϭ 0) were nearly decrease in vital capacity, and an increase in RV/TLC ratio from identical (Sa O 2 : before ϭ 96.8 Ϯ 0.8%; after ϭ 95.3 Ϯ 2.4%).
a BAS of 0.25 to 0.41. BLVR was followed by decreases in RV Supplemental oxygen therapy or reintubation was not required in any of the sheep. All animals were active, eating, and behaving and TLC, an increase in vital capacity, and a decrease in RV/ Figure 4 . DL CO diffusing capacity at baseline (BAS), after development of emphysema (EMPH), 3 weeks after BLVR (BLVR-1), and 9 weeks after BLVR (BLVR-2). At BLVR-2, the DL CO value and was not appreciably different from BAS.
(47.9 Ϯ 13.7 at BAS versus 41.0 Ϯ 4.5 ml/min/mm Hg at 9 weeks after BLVR; p ϭ 0.31) (Figure 4 ). Autopsy, performed 9 weeks after BLVR, showed grossly TLC-2 ϭ after papain; TLC-4 ϭ 9 weeks after BLVR.
visible, well-demarcated, zones of whitish-appearing scar tissue on the pleural surfaces of the lung at 33 of the 36 targeted sites in the six animals ( Figure 6 ). These locations corresponded to sites of fibrin hydrogel injections and to the linear densities TLC ratio to 0.21 at 3 weeks. At 9 weeks RV/TLC ratio remained observed on CT scan. decreased at 0.26.
Microscopic examination of the lungs revealed that papain Airway resistance increased after papain administration but exposure had produced diffuse tissue destruction with heterogereturned to pre-EMPH BAS values by 9 weeks post-BLVR. neity in air space size. The pattern of destruction resulting from Tissue resistance and dynamic elastance were unaffected by papain nebulization was most consistent with panlobular detreatment. Dl CO declined significantly after papain exposure but struction. At sites of BLVR treatment, extensive collagen deposhowed a trend back toward BAS at 9 weeks. This value did sition, with collections of fibroblasts and mononuclear cells, connot differ appreciably from that observed at BAS before papain sistent with organized scar tissue was observed. There was no suggestion of pneumonitis, granuloma formation, residual foreign body material, or evidence of tissue necrosis or abscess formation (Figures 7 and 8) .
DISCUSSION
The present study represents the application of a novel strategy for treating pulmonary EMPH by promoting formation of scar tissue to replace diseased hyperinflated lung parenchyma. Because the scar tissue occupies a much smaller volume than the associated air-filled and hyperexpanded lung from which it derives, the process reduces overall lung volume. Although no new functioning lung tissue is created during BLVR, the resizing of the lung ameliorates a mismatch between the hyperinflated lung and the nonyielding rigid chest cage. This anatomic disparity is a fundamental disturbance that governs the pathophysiology of EMPH, and the resizing that follows volume reduction therapy significantly improves lung function. In contrast to more tradi- residual volume, TLC ϭ total lung capacity, and VC ϭ vital capacity. RV/TLC ratio increased after EMPH was established but fell after BLVR.
The sheep model of advanced homogenous EMPH used in the present study displayed a more severe form of disease than logic responses to volume reduction were therefore not dependent on the location of treatment sites but rather the total numthe model employed in previous BVLR experiments. In this ber of treatment sites. The sites treated with BLVR included earlier experimental model of mild-to-moderate EMPH, papain both dependent and nondependent areas to permit evaluation was administered during spontaneous breathing (10) . In the presof the BLVR system's ability to safely treat areas located ent study, nebulized papain was delivered after bronchodilator throughout all regions of the lung. Results presented here contherapy and during positive pressure mechanical ventilation usfirm that target areas can be readily identified without imaging ing relatively large tidal volumes (12 ml/kg). This modification guidance and that both dependent and nondependent regions in technique produced more severe tissue damage and correcan be safely treated without reagent migration or spill-over into spondingly greater physiologic disturbances without detectable adjacent nontarget areas of lung. pleural or parenchymal scarring or persistent inflammation ob-BLVR was performed in a fashion nearly identical to convenserved at 9-week follow-up. One animal did develop respiratory tional bronchoalveolar lavage and was well tolerated by all distress and pulmonary hemorrhage after two doses of papain sheep. No major adverse systemic responses were observed durand was killed. The remaining six tolerated the papain treatments ing or after completion of the procedures. The animals recovered with only mild side effects.
quickly and did not manifest clinically detectable respiratory The physiologic disturbances after papain exposure were of distress. They were standing, walking, and eating within an hour moderate severity and were evident 2 weeks after completion of removal of the endotracheal tube and discontinuation of anesof treatments. RV, an indicator of trapped gas, rose by 66% but thesia (propofol), and resumed normal activity within hours of TLC increased by only 8%. The disproportionate increment in BLVR therapy. RV relative to TLC resulted in an impressive decline both in CT scan images showed local consolidation and collapse in vital capacity (21%) and elastic recoil pressure (48%). Dl CO also the target territory immediately after BLVR. These early radiofell by 21%. The tissue destruction found at autopsy explains graphic changes evolved into linear densities on CT image after the profound physiologic changes and marked loss of surface 9 weeks ( Figure 5 ) and corresponded to the location of peripheral area for gas exchange.
scars observed at necropsy. There was no evidence of pleural Because this experimental model displayed homogeneous effusion, pleural scarring, or lung abscesses at any of the treatment sites. EMPH, target sites of severe damage were not evident. Physio- BLVR was followed by impressive reductions in both TLC than mechanical obstruction (11). As summarized here, results were substantially better using this modified approach. Effective-(17% at 3 weeks and 16% at 9 weeks, p ϭ 0.02) and RV (56% at 3 weeks, p ϭ 0.002; 41% at 9 weeks, p ϭ 0.01). Analysis of ness rose from 55 to 91% (33/36 versus 11/20 sites with scar formation, p Ͻ 0.001 by 2 ), and safety improved as demonstrated static lung volumes by the Campbell diagram indicates that the improvements in vital capacity and recoil pressure observed were by the drop in sterile abscess formation from 15 to 0% (0/36 sites versus 3/20 sites with sterile abscess formation, p ϭ 0.025 largely due to a decrease in trapped gas volume (RV). At 3 weeks post-BLVR, part of the reduction in gas volume may by 2 ). Simple mechanical approaches to volume reduction have have been due to consolidation in the target territory from the injection of reagents. However, these areas of parenchymal conbeen tested by other investigators and have met with problems. At least two groups have placed occlusive materials and devices solidation radiographically evolved into linear densities, and the organized, contracted scar tissue found at necropsy 6 weeks later, within the proximal airways to generate volume reduction, but to our knowledge no appreciable lasting physiologic benefits suggests that lung volume was getting smaller. Anatomic findings combined with improvements in physiologic indices provide have been obtained (18, 19) . In one instance, the procedure was associated with serious complications, including pneumothorax, strong evidence for a cause and effect relationship between BLVR-induced scar formation and volume reduction.
pneumonia, and hemorrhage (19). Inability to collapse target areas using devices deployed within the proximal bronchi has Our initial attempt at BLVR had focused on a mechanical approach for generating volume reduction through occlusion of been attributed to extensive collateral ventilation within the periphery of the EMPH lung (20, 21) . In patients with advanced segmental bronchi using relatively large aliquots (50 ml) of fibrin hydrogel. The results were somewhat disappointing because only disease, resistance to airflow through collateral channels may be equivalent to or less than that through anatomic airways, making 55% (11/20) of the targeted areas demonstrated sustained atelectasis and scar. In addition, there was a 15% (3/20) incidence volume reduction using a strategy based on proximal obstruction difficult, if not impossible. In those areas where collapse can be of sterile abscess formation. We postulated that the failure to produce sustained collapse at all target sites might have been achieved, retained secretions can predispose to postobstructive infections. due to potent endogenous plasmin activity at the lung epithelial surface leading to rapid degradation of fibrin gel at some injecThis new, nonsurgical BLVR system based on principles of tissue engineering involves the safe, controlled removal of brontion sites. We further postulated that sterile abscesses were probably the result of pressure necrosis due to filling of lobules chial epithelial lining cells and deployment of a fibrin hydrogel into the airways of hyperinflated emphysematous areas of lung with relatively large volumes of hydrogel injectate that on crosslinking generate local hydrostatic pressures that exceed capillary to provide a scaffold for fibroblast chemotaxis and attachment, leading to the evolution of localized scar tissue formation. The perfusion pressure. Concerns regarding effectiveness as well as safety of the original BLVR approach, led to the development 91% success rate of achieving scar formation in the targeted territory and the associated improvement in pulmonary function of a new generation BLVR based on biologic modulation rather suggest that the scar shrinks the hyperinflated lung and reduces areas of V /Q imbalance during the procedure, and therefore reduces the tendency for acute hypoxemia. It can even be argued overall lung volume. The absence of sterile abscess formation indicates that this second-generation BLVR procedure adthat larger disturbances in gas exchange might be anticipated in the sheep that have less BAS lung damage and are therefore dresses the safety concerns associated with the initial approach.
Although these data support the effectiveness and safety of more prone to acute hypoxemia as a result of development of new zones of altered V /Q during BLVR. In our studies, little this new procedure as applied to sheep with EMPH, differences in physiology between the animal model and human disease acute desaturation was, in fact, observed, and all animals recovered rapidly from BLVR without evidence of respiratory insufficould influence anticipated clinical responses. The sheep studied here demonstrated substantial tissue destruction and hyperinflaciency. Thus, it can be reasonably argued that this modified approach to BLVR that uses small volumes of injectate and tion. However, gas exchange was affected to a lesser degree. Resting room air saturations in sheep after papain exposure targets only the most dysfunctional areas of lung is unlikely to cause significant alterations in arterial oxygenation in patients, before BLVR ranged from 93 to 97%. By contrast, the majority of patients considered for volume reduction therapy require even when abnormalities in BAS gas exchange exist. The absence of BAS hypoxemia in this model also precludes supplemental oxygen to maintain arterial saturation levels greater than 90%. Therefore, this sheep model does not accuevaluation of any beneficial effects of BLVR on oxygenation. However, we do not consider this to be a significant limitation rately reproduce the hypoxemia observed in humans with advanced EMPH who are candidates for volume reduction. It is because volume reduction therapy has not been shown to produce consistent clinical benefits with respect to oxygenation (22), therefore possible that BLVR could pose a greater risk of procedure-related hypoxemia in patients than was observed in sheep.
and thus such benefits are not necessarily expected from BLVR. Improvement in respiratory function after volume reduction However, several factors mitigate against this supposition. Only the most damaged and dysfunctional regions of lung are targeted therapy occurs independent of effects on oxygenation.
Although differences in patterns of collateral ventilation do, for BLVR treatment. The ability to target only these regions for volume reduction minimizes the likelihood of producing new in fact, exist between humans and ruminants in general, studies lung is quite similar (23) . Furthermore, the success of this proce- 
